SC Pharmaceuticals Inc
(SCPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -85,148 | -54,810 | -36,838 | -28,034 | -32,209 |
| Depreciation Amortization | 20 | 24 | 37 | 438 | 399 |
| Accounts receivable | -7,289 | -4,489 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 592 | 5,556 | 1,767 | -2,365 | 1,212 |
| Other Working Capital | -13,092 | -6,321 | -350 | -2,599 | 1,448 |
| Other Operating Activity | 34,379 | 796 | 807 | 5,409 | 1,457 |
| Operating Cash Flow | $-70,538 | $-59,244 | $-34,577 | $-27,151 | $-27,693 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 29,320 | 20,005 | -45,838 | 32,139 | -33,460 |
| PPE Investments | -21 | -40 | -21 | -9 | N/A |
| Investing Cash Flow | $29,299 | $19,965 | $-45,859 | $32,130 | $-33,460 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 46,772 | N/A | 47,301 | N/A | N/A |
| Debt Repayment | -50,000 | N/A | -17,500 | -2,500 | N/A |
| Common Stock Issued | 53,775 | 354 | 46,689 | 9 | 50,924 |
| Other Financing Activity | 19,533 | 14,496 | 739 | -39 | 9,424 |
| Financing Cash Flow | $70,080 | $14,850 | $77,229 | $-2,530 | $60,348 |
| Beginning Cash Position | 46,814 | 71,243 | 74,450 | 72,001 | 72,806 |
| End Cash Position | 75,655 | 46,814 | 71,243 | 74,450 | 72,001 |
| Net Cash Flow | $28,841 | $-24,429 | $-3,207 | $2,449 | $-805 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70,538 | -59,244 | -34,577 | -27,151 | -27,693 |
| Capital Expenditure | -21 | -40 | -21 | -9 | N/A |
| Free Cash Flow | -70,559 | -59,284 | -34,598 | -27,160 | -27,693 |